28
Apr

Merck execs used their quarterly review today to confirm that the troubled drug Bridion (sugammadex) has once again been rejected at the FDA. This is the drug’s third stiff arm at the agency.

…read more

Source: FDA bats down Merck’s sugammadex in third rejection

    

0 No comments